Dementia prevention, intervention, and care: 2020 report of the Lancet Commission | Lancet, The | 2020 | 1.4K |
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease | Autoimmunity Reviews | 2020 | 938 |
Vaccine hesitancy: the next challenge in the fight against COVID-19 | European Journal of Epidemiology | 2020 | 629 |
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics | Drug Development Research | 2020 | 513 |
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia | Lancet Rheumatology, The | 2020 | 460 |
The human tumor microbiome is composed of tumor type-specific intracellular bacteria | Science | 2020 | 379 |
Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance | Comprehensive Psychiatry | 2020 | 283 |
European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020 | Journal of Pediatric Gastroenterology and Nutrition | 2020 | 271 |
Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study | Circulation | 2020 | 265 |
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations | Annals of Oncology | 2020 | 262 |
Covid-19 and autoimmunity | Autoimmunity Reviews | 2020 | 248 |
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis | Gastroenterology | 2020 | 234 |
Fear of COVID-19 scale: Psychometric characteristics, reliability and validity in the Israeli population | Psychiatry Research | 2020 | 220 |
Periodontitis and cardiovascular diseases: Consensus report | Journal of Clinical Periodontology | 2020 | 220 |
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study | FEBS Journal | 2020 | 212 |
Joint international consensus statement for ending stigma of obesity | Nature Medicine | 2020 | 210 |
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial | Lancet, The | 2020 | 201 |
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study | Leukemia | 2020 | 185 |
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility | British Journal of Dermatology | 2020 | 179 |
Immune-mediated approaches against COVID-19 | Nature Nanotechnology | 2020 | 178 |
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature | Journal of Dermatological Science | 2020 | 169 |
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database | Genetics in Medicine | 2020 | 164 |
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial | Lancet, The | 2020 | 162 |
Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50 | Obesity | 2020 | 157 |
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 | European Urology | 2020 | 155 |